Ally Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,000
| Closed | -$1.12M | – | 106 |
|
|
2025
Q2 | $1.12M | Buy |
+4,000
| New | +$1.13M | 0.13% | 92 |
|
|
2025
Q1 | – | Sell |
-4,000
| Closed | -$1.04M | – | 114 |
|
|
2024
Q4 | $1.04M | Buy |
+4,000
| New | +$1.19M | 0.13% | 91 |
|
|
2024
Q2 | – | Sell |
-4,000
| Closed | -$1.14M | – | 115 |
|
|
2024
Q1 | $1.14M | Buy |
+4,000
| New | +$1.17M | 0.15% | 90 |
|
|
2023
Q3 | – | Sell |
-12,000
| Closed | -$2.66M | – | 108 |
|
|
2023
Q2 | $2.66M | Buy |
+12,000
| New | +$2.78M | 0.37% | 59 |
|
|
2022
Q1 | – | Sell |
-12,000
| Closed | -$2.7M | – | 122 |
|
|
2021
Q4 | $2.7M | Hold |
12,000
| – | – | 0.25% | 73 |
|
|
2021
Q3 | $2.55M | Hold |
12,000
| – | – | 0.25% | 77 |
|
|
2021
Q2 | $2.92M | Hold |
12,000
| – | – | 0.29% | 80 |
|
|
2021
Q1 | $2.99M | Buy |
12,000
+5,000
| +71% | +$1.19M | 0.28% | 80 |
|
|
2020
Q4 | $1.61M | Hold |
7,000
| – | – | 0.15% | 100 |
|
|
2020
Q3 | $1.78M | Hold |
7,000
| – | – | 0.29% | 80 |
|
|
2020
Q2 | $1.65M | Hold |
7,000
| – | – | 0.27% | 79 |
|
|
2020
Q1 | $1.42M | Buy |
+7,000
| New | +$1.53M | 0.15% | 94 |
|
|
2019
Q3 | – | Sell |
-6,000
| Closed | -$1.11M | – | 107 |
|
|
2019
Q2 | $1.11M | Buy |
+6,000
| New | +$1.07M | 0.19% | 89 |
|
|
2018
Q3 | – | Sell |
-8,000
| Closed | -$1.48M | – | 107 |
|
|
2018
Q2 | $1.48M | Hold |
8,000
| – | – | 0.29% | 87 |
|
|
2018
Q1 | $1.36M | Hold |
8,000
| – | – | 0.2% | 106 |
|
|
2017
Q4 | $1.39M | Buy |
+8,000
| New | +$1.42M | 0.27% | 87 |
|
|
2017
Q3 | – | Sell |
-25,000
| Closed | -$4.31M | – | 110 |
|
|
2017
Q2 | $4.31M | Buy |
25,000
+13,000
| +108% | +$2.11M | 0.85% | 40 |
|
|
2017
Q1 | $1.97M | Sell |
12,000
-6,000
| -33% | -$997K | 0.44% | 82 |
|
|
2016
Q4 | $2.63M | Buy |
+18,000
| New | +$2.71M | 0.44% | 60 |
|
|
2016
Q3 | – | Sell |
-35,000
| Closed | -$5.33M | – | 101 |
|
|
2016
Q2 | $5.33M | Hold |
35,000
| – | – | 0.89% | 30 |
|
|
2016
Q1 | $5.25M | Hold |
35,000
| – | – | 0.73% | 33 |
|
|
2015
Q4 | $5.68M | Buy |
35,000
+4,900
| +16% | +$770K | 0.79% | 32 |
|
|
2015
Q3 | $4.16M | Buy |
30,100
+5,100
| +20% | +$804K | 0.42% | 63 |
|
|
2015
Q2 | $3.84M | Buy |
25,000
+3,000
| +14% | +$481K | 0.39% | 68 |
|
|
2015
Q1 | $3.52M | Buy |
+22,000
| New | +$3.46M | 0.36% | 80 |
|
|
2014
Q3 | – | Sell |
-45,000
| Closed | -$5.33M | – | 130 |
|
|
2014
Q2 | $5.33M | Buy |
45,000
+23,000
| +105% | +$2.66M | 0.63% | 59 |
|
|
2014
Q1 | $2.71M | Buy |
+22,000
| New | +$2.67M | 0.29% | 107 |
|
Other funds holding AMGN
Ally Financial's AMGN Position: Q3 2025 in Review
Ally Financial sold out of Amgen (AMGN) in Q3 2025, closing a stake of 4,000 shares — an estimated $1.12M sold.
Ally Financial first reported a position in AMGN in Q1 2014 and held it in 27 quarters. The position peaked at $5.68M in Q4 2015. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Ally Financial reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Ally Financial sold 4,000 Amgen shares in Q3 2025, an estimated $1.12M.
- Ally Financial first reported a position in Amgen in Q1 2014 and held it in 27 quarters.
- Ally Financial's Amgen position peaked at $5.68M in Q4 2015.
- 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Ally Financial's 13F filing for Q3 2025, filed 13 Nov 2025.